chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EL3247, unknown expiration), via an unspecified route of administration in right arm on 19Jan2021 at a single dose for COVID-19 immunization in a workplace clinic.  Medical history included hypothyroidism, idiopathic thrombocytopenic purpura (ITP), and previously administered dermal fillers in Jun2020.  The patient has no allergies to medications, food, or other products. Concomitant medications included levothyroxine, tamoxifen, and vitamin D.  The patient also received her first dose of BNT162B2 (lot number: EJ1685, unknown expiration) for COVID-19 immunization in right arm on 29Dec2020. The patient experienced swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness on 21Jan2021. The patient received steroids and antihistamines. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient recovered from the events on unspecified date. The events were assessed as non-serious.  No follow-up attempts are possible. No further information is expected.
feels awful; chills; Arm pain; Nausea; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), FEELING ABNORMAL (feels awful), NAUSEA (Nausea), FATIGUE (tiredness) and CHILLS (chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm pain), NAUSEA (Nausea) and FATIGUE (tiredness). On 28-Mar-2021, the patient experienced FEELING ABNORMAL (feels awful) and CHILLS (chills). On 12-Mar-2021, PAIN IN EXTREMITY (Arm pain), NAUSEA (Nausea) and FATIGUE (tiredness) had resolved. At the time of the report, FEELING ABNORMAL (feels awful) and CHILLS (chills) outcome was unknown.            Products known to have been used by the patient, within two weeks prior to the event were not provided. Concomitant medications were not provided. No laboratory investigations were provided. The Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.   This case was linked to MOD-2021-061117 (Patient Link).
On 9/22/00, pt had redness around injection site. It was very sore with a bump and discoloration.
On the morning of admission, patient had another episode.  She was sitting at the kitchen table and then slumped forward unconscious.  She has no memory of the episode.  Daughter is unsure how long she was unconscious for.  She was taken to the ER via ambulance.  Head CT in the ER showed only age-related changes.  Chest x-ray showed an increase in infiltrate.  Influenza test negative.  Rapid COVID-19 test negative.  Urinalysis only had 2+ leukocyte esterase.  White count of 3.3.  Cardiac enzymes negative.  BNP normal.  remains hospitalized at Hospital - inpatient
Oral lesions appeared all over inside my mouth, on my tongue, cheeks, behind my lower lip, and gums; It began with a few white-colored sores; my tongue never felt right. It felt as though the top layer was numb; This is a spontaneous report from a contactable consumer (patient). A 48-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in the right arm on 07Mar2021 11:45 AM (Batch/Lot Number: EN6199) at the age of 48-years-old as 1st dose, single for COVID-19 immunization at urgent care center. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient's medical history included asthma, arthritis, and allergies: sensitive to peppers. Concomitant medication included meloxicam taken for an unspecified indication, start and stop date were not reported (received within 2 weeks of vaccination). On 08Mar2021, oral lesions appeared all over inside her mouth, on her tongue, cheeks, behind her lower lip, and gums. It began with a few white-colored sores. They would heal and new ones would appear. They lasted for 2 weeks. While the sores were gone, her tongue never felt right. It felt as though the top layer was numb. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient has not been tested for COVID-19. A device date of 09May2021 was reported. Therapeutic measures were taken as a result of the events which included valacyclovir hydrochloride (VALTREX), chlorhexidine gluconate (PERIDEX), triamcinolone, and B12. The outcome of the events was recovered with sequelae (recovered with lasting effects).
Pt recv vax on 2/5/98; on 2/7/98 pt exp hives of upper body, facial/extremity edema & tight throat/chest; dx=anaphylaxis; tx=Epinephrine, nebulizer & steroids
1.  Severe chills and body aches started about 7 hours post vaccination. Along with severe headache.   Severe chills lasted about 6 hours.   2.  High temperature of 103 lasted for 5 or 6 hours.  Temperature went down to 100-101 for another 10 hours.  Tylenol every 4 hours didn?t seem to help. 3.  Chills, body ache and headache were so bad that I could barely walk.   4.  Fever and headache subsided after about 35 hours.
The reaction to the shot was that she had alcohol taste, nausea, wretching, and a rapid response team was called and she was taken to the ED.
Raised swollen and firm semi circle at the injection site. Tender to touch but no real pain or heat from the location.  Was gone within 24 hours at an estimate.
Developed chicken pox on 7/12/2004. Vaccinated on 7/2/98. she has been treated for all. Done with Chemotherapy x 2 years. Diagnosed 12/99. Has CP now.
Rash and hives started on day 4, starting on my left hand, and extending to my stomach, chest, back, arms and legs. Started prednisone steroid on day 7 as the itching and pressure on my chest from swelling on my organs was so severe. The steroids stopped the rash. However, it further depleted my immune system such that by day 11, I started with diarrhea,  severe sore throat, fever, and tightness in my chest.
This spontaneous report as received from a medical assistant refers to multiple, unspecified patients. The patients' concurrent conditions, medical history and concomitant therapies were not reported. From 23-AUG-2015 to 02-OCT-2015, the patients were vaccinated with doses of improperly stored VARIVAX (Merck) lot # L016127 with expiration date 06-MAY-2017 and lot # L011083 with expiration date: 23-AUG-2017. No adverse effects were reported. Additional information has been requested.
7-8 hours after receiving vaccine, experienced headache, nausea, dizziness, chills, and body aches.  The headache subsided after two hours but the dizziness and nausea remained through the night.  Perspired all night. By morning, all symptoms gone except very tired.  24 hours after receiving shot, back to normal state.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 67-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 23Jan2021 as dose 1, single (Lot number: EL9262), in left arm, on 10Feb2021 as dose 2, single (Lot number: EN6201), in left arm, on 25Sep2021 as dose 3 (booster), single (Lot number: FF8839), in left arm and on 31Mar2022 as dose 4 (booster), single (Lot number: FM0698) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: sulfa based drugs" (unspecified if ongoing), notes: Known allergies: sulfa based drugs. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Additional information: Antiviral details: product=COVID-19 Treatment, Treatment start date=18Jun2022, Treatment stop date=23Jun2022, indication=Treatment of COVID-19. This case assessed as non-serious by the reporter.
Headache started 2 to 3 days after vaccination,  Patient had fever for 2 days. Patient's arm feeling  sore and heavy at the injection site.  Patient is feeling better 5 days after vaccination. Patient consulted  the doctor regarding her symptoms.
Petechiae, purpura. ITP 23 days following MMR. Platelet count 2K. Given IVIG.
Fever 104 degrees, swelling left leg. 25th seen in ER. Rechecked in our office 11/30/09, 799.2. 11/30/09 Dx and Rx bronchitis/sinusitis Rx ZITHROMAX.
Dizziness, Headache, Myalgia, Arthralgia, Fever & CoughWheeze
Dizziness, Tachypnea, CoughWheeze, Palpitations,  shortness of breath, throat tightness Narrative:  VAccine administered at 12:15pm. At 1230pm, employee noted new cough and onset of sob/throat tightening. O2 sat 96-97% on RA, HR 110-120's, BP 123/90. Employee with a long history of environmental/food allergies, occasionally requiring epi-pen. Epi-pen (0.3mg) administered IM x1. 25 mg IV benadryl administered x1. Employee reported symptom improvement after this medication administration and was taken to the ED for further eval. In ED given IV famotidine 20mg x1. Employee monitored without any further adverse reaction. Discharged home with RX for Famotidine 20 mg twice a day for 5 days and Zyrtec 10 mg twice a day for 5 days.
low grade temp 99.4-100 x 5 days p/vax;rash to chest & back x 2 days;soreness lt arm x 3 days @ vax site;body aches, tiredness x 4 days;buffered ASA as needed;
Local reaction within 15 min of injection, redness, itching and hives lasting several hrs. (6 known reactions from 2 vials) total of 20 injections given
Rash on face, stomach, back and bottom. Fever, fussy for 2 days. Reaction to vaccines listed below.
Patient presented with fever, cough, body aches, chills, weakness, headaches, SOB.
Patient collapsed to the floor and sustained a seizure <1min. patient states LOC. parent of the patient states no prior hx of seizure.
On 05/03/2022 which was one month after receiving dose 4 I woke up in extreme pain in my left hip, back and radiating down my leg.  Also was in my left groin and pelvis area. At this point I called 911 and was taken to the ER. I have seen my doctor, been to the ER twice and also seen an orthopedic pain specialist for the extreme pain. Two days after the ER visit I woke up with a roaring pain again and had to call 911 and ended up back in the ER. I have had several steroid injections in my hips and back along with a CT scan of my abdomen and it was negative.  I have already had 2 rounds of oral steroids with very little relief.  I will be meeting again with my doctor to discuss setting up a MRI.  I usually walk for an hour a day and worked in my garden but my strength has diminished  to where I couldn't quite get these things done.
SkinRash, One inch by one inch erythematous area vert tender centrally right upper arm. Warm to touch and swollen. Narrative:
dizzy; nauseous; fever of 98.7; throw up; This is a spontaneous report from a non-contactable consumer. This consumer reported for a female patient (wife) that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration on Feb2021 (Batch/Lot number was not reported) as dose 1, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. In Feb2021, the patient experienced dizzy, nauseous, fever of 98.7 and throw up. The consumer said his wife received the 1st dose of the Pfizer-BioNTech Covid-19 Vaccine on Monday afternoon. However, he said that this morning, his wife woke up and could not get out of bed, was very dizzy, nauseous, shows a little fever of 98.7 F and has attempted to throw up. He said he called to seek guidance on what to do about these side effects. The patient underwent lab tests and procedures which included body temperature: 98.7 Fahrenheit on Feb2021. The outcome of the events was unknown.   No follow-up attempts are possible. No further information is expected. Information regarding Lot/Batch No. cannot be obtained.
1 yr vaccines given May 2015 followed 8 hours later total body rash and swelling, relieved by epinephrine, BENADRYL and steroids, received MMR varicella, HepA, and PEC 13 at time. Has had DTaP Hep A and flu vaccines since then without problems.
This case was reported by a healthcare professional and described the occurrence of swelling injection site in a 64-year-old female subject who was vaccinated with FLULAVAL (GlaxoSmithKline). The subject's medical history included arm pain. On 3 October 2010 the subject received dose of FLULAVAL (subcutaneous, left arm) and experienced inappropriate route of vaccination. FLULAVAL should be administered by the intramuscular route. The lot number was reported as AFFL59BA. On 3 October 2010, 8 days after vaccination with FLULAVAL, the subject experienced swelling injection site and injection site tenderness. At the time of reporting the swelling injection site and injection site tenderness were resolved. The healthcare professional considered the swelling injection site and injection site tenderness were probably related to vaccination with FLULAVAL.
This case was reported by a consumer and described the occurrence of low grade fever in a 7-month-old male subject who was vaccinated with HAVRIX (GlaxoSmithKline), (non-gsk) PREVNAR and (non-gsk) PENTACEL. A physician or other health care professional has not verified this report. On 2 March 2010 at 15:00 the subject received 1st dose of HAVRIX (unknown, left thigh), unspecified dose of PREVNAR (unknown, unknown thigh) and unspecified dose of PENTACEL (unknown, unknown thigh). On 2 March 2010, at the time of vaccination with HAVRIX, the subject experienced wrong vaccine administered. The mother reported the subject received HAVRIX instead of his 3rd dose in the series of Hepatitis B vaccine "because the vaccine cap was the same color". On 2 March 2010, 6 hours after vaccination with HAVIRX, PENTACEL and PREVNAR, the subject experienced low grade fever and soreness in thigh. The subject's mother indicated that the thigh soreness and low-grade fever could have been caused by other vaccines. At the time of reporting the outcome of the low grade fever and soreness in thigh was unresolved.
redness, swelling, itchy-treatment Benadryl. Resolved in 24 hours.
headache; congestion; Tightness in chest; This is a spontaneous report from a contactable consumer (Patient). A 66-year-old female patient received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), Solution for injection, via an unspecified route of administration on 01Feb2021 as single dose for covid-19 immunisation. Medical history included diabetes mellitus.Concomitant medications included Vitamin B6 and Glipizide. On an unspecified date, the patient experienced headache, congestion and tightness in chest. The outcome of event was unknown. Patient got the First vaccine which she got 3 weeks ago today and she was due to get the second of the Pfizer vaccine. She confirmed it was the Pfizer COVID 19 vaccine. She said everything was going really well up until the middle of last week and then for about 4 days she had headaches that wouldn't go away. She had cold symptoms like congestion, she had tightness in the chest and finally they started going away yesterday except the headache and it is a different kind of headache almost like a migraine it was sharp. She wanted to know, should she go ahead and get the second dose as scheduled today at 3:40 PM even though she has possibly been exposed. She did have blood tests done and it was really high on the B6 her levels. So she stopped her over the counter vitamin on B6. Her diabetic numbers according to one doctor are not on a good level. Her 3 months numbers had been really good. The other doctor said it was fine, the doctor she has been with said it was fine, but her primary was on vacation and someone else read her fasting blood sugar. She is borderline diabetic, but she doesn't take Glipizide anymore because she eats a vegan no sugar, little fruit, and very little carb diet. The outcome of headache was not recovered and all other events were recovering.   Follow-up attempts are completed. No further information is expected.
How long will my side effects last??/Consumer answered "Yes" to having side effects/experienced a side effect; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (How long will my side effects last??/Consumer answered "Yes" to having side effects/experienced a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (How long will my side effects last??/Consumer answered "Yes" to having side effects/experienced a side effect). At the time of the report, ADVERSE REACTION (How long will my side effects last??/Consumer answered "Yes" to having side effects/experienced a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product was not provided by the reporter  Treatment information was not provided   Reporter did not allow further contact
pt recvd vax; devel local rxn & bad joint pain which progressively worsened over 3 days;CBC nl; SGOT elev & pt also had elev BUN/creatinine ratio; arthralgias resolved p/ several days;
I experienced three days later bilateral leg pain, left greater than right., I also had headaches that were constant. I went to urgent care where they did exams.  I can say that to this day I still have leg pain, L>R and some headaches that come and go.
pt recv vax 19APR96 & 2MAY96 pt devel a vesicular, pimple-like rash w/8-10 lesions;there was no assoc fever;no further details were provided;
Information has been received from a registered nurse concerning a 67 year old female with osteopenia and penicillin allergy and a history of chronic right leg injury due to motor vehicle accident, splenectomy and calculus renal who on 28-NOV-2006 was vaccinated intramuscularly in the left deltoid with the second dose of Pneumovax 23 (0.5 ml) (Lot # 655499/0988F). Concomitant therapy included ACTONEL, MAXAIR and calcium (unspecified). On 28-NOV-2006 the patient experienced pain at the injection site of the left deltoid which began a few hours after vaccination. Examination by the patient's physician on 29-NOV-2006 revealed a left deltoid muscle tenderness to palpation. Ice compresses and ADVIL was prescribed. The patient returned on 13-DEC-2006 complaining of continued pain. The physician recommended physical therapy which at the time of this report was ongoing. The patient's symptoms have improved but were not resolved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/30/2007. Initial and follow-up information has been received from a registered nurse and physical therapy notes concerning a 67 year old female with osteopenia and penicillin allergy and a history of chronic right leg injury due to motor vehicle accident, splenectomy and calculus renal who on 28-NOV-2006 at noon, was vaccinated intramuscularly in the left deltoid with the third dose of PNEUMOVAX vaccine (0.5 mL) (Lot # 655499/0988F). The patient had eczema at the time of vaccination. Concomitant therapy included ACTONEL, MAXAIR and calcium (unspecified). On 28-NOV-2006, at 4:00 PM, the patient experienced pain with any movement of the left arm which began several hours after vaccination. Examination by the patient's physician on 29-NOV-2006 revealed a left deltoid muscle tenderness to palpation. Ice compresses and ADVIL was prescribed. The patient returned on 13-DEC-2006 complaining of continued pain. The physician recommended physical therapy. Upon assessment from physical therapy, the patient complained of pain with functional range of motion less that 1/10. Diagnosis at the time included muscle spasms and joint pain. Physical therapy included ultrasound, moist heat, ice/cold pack, PROM. AROM, AAROM, strengthening, electric stim, joint mobilization, TENS, HEP, message and home exercise instructions. On 19-JAN-2007 the patient reporting that she was able to hold her hair drier better but continued to have problems reaching overhead especially dressing/grooming, and push/pull tasks. The patient also complained of being unable to get up from the floor and having sleeping difficulty. With difficulty getting comfortable and awakening 2 to 3 times per night. On 16-MAR-2007, the patient was discontinued from physical therapy after having slowly made gains, however continued to have pain with range of motion and ADL's. No further information is expected.
This spontaneous report was received from a registered nurse referring to a patient of currently 60 years of age and unspecified gender. The patient's pertinent medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with improperly stored ZOSTAVAX, lot # L035283, expiry date: 15-DEC-2016 (dose, route of administration and anatomical location not reported). The doses of ZOSTAVAX underwent temperature excursion: 14.7F for 2 hours and 15 minutes. There were no previous temperature excursions. No symptoms were reported. No previous quality complaint (PQC) was involved. No further information was provided. This is one of several reports from the same source. Additional information has been requested.
The nurse was putting a bandage on her arm which was bleeding.  My daughter fainted, her head went back, her eyes rolled into her head and her whole body went stiff.  After this, she went limp and her face turned a very dark blue then went pale.  Her lips were so blue, they almost looked black. When she came to, she said she remembered having a hard time taking a breath.  She also couldn't focus and didn't even know I was in the room holding her hand.  She has never had any other type of reaction to an injection.  She gets a yearly flu shot.  She is also current with her MCV4, and Tdap.
has baseline cough, developed diarrhea x3 episodes 1/7/2022, tested positive for covid on Abbott ID now molecular test